Diabetes: Insulet and Dexcom call it quits on development agreement

February 7, 2013 by Arezu Sarvestani

Insulet and Dexcom decide not to pursue a joint development agreement to integrate Dexcom's continuous glucose monitoring technology with Insulet's insulin-infusing OmniPod.

Broken handshake illustration

Get the complete picture with a MassDevice Plus membership. Registered users can login here.